| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Departments of Research and Medicine, Saint Francis Hospital and Medical Center (R.C.P., F.B., E.C.), Hartford, Connecticut 06105; University of Connecticut School of Medicine (E.C.), Farmington, Connecticut 06030; and Universidade de São Paulo (R.C.P.), São Paulo, Brazil
Address all correspondence and requests for reprints to: Ernesto Canalis, M.D., Department of Research, Saint Francis Hospital and Medical Center, 114 Woodland Street, Hartford, Connecticut 06105-1299. E-mail: ecanalis{at}stfranciscare.org
Glucocorticoids inhibit the synthesis of insulin-like growth factor I
(IGF-I) and regulate the expression of IGF-binding proteins
(IGFBPs) in osteoblast cultures. IGFBP-related protein-1
(IGFBP-rP1), the product of the mac25 gene, binds IGF-I, IGF-II, and
insulin, and we postulated that glucocorticoids regulate IGFBP-rP1
synthesis in osteoblasts. We tested the expression of mac25/IGFBP-rP1
in cultures of osteoblast-enriched cells from 22-day-old fetal rat
calvariae (Ob cells). Cortisol treatment at 10 nM to 1
µM for 2448 h caused a time- and dose-dependent
increase in mac25/IGFBP-rP1 messenger RNA (mRNA) levels in Ob cells.
Cycloheximide at 3.6 µM did not alter
mac25/IGFBP-rP1 transcripts in control or cortisol-treated cells.
Cortisol did not modify the decay of mac25/IGFBP-rP1 mRNA in
transcriptionally arrested Ob cells and increased the rate of
IGFBP-rP1 transcription as determined by nuclear run-on assays.
Retinoic acid also increased mac25/IGFBP-rP1 mRNA levels, but
17ß-estradiol, testosterone, 5
-dihydrotestosterone,
progesterone, and 1,25-dihydroxyvitamin D3 did
not. In conclusion, cortisol stimulates mac25/IGFBP-rP1 expression in
Ob cells by transcriptional mechanisms. As IGFBP-rP1 binds and possibly
modifies the effects of IGFs and insulin, its increased expression
could be relevant to the inhibitory actions of cortisol in bone.
This article has been cited by other articles:
![]() |
T. Usui, T. Murai, T. Tanaka, K. Yamaguchi, D. Nagakubo, C. M. Lee, M. Kiyomi, S. Tamura, Y. Matsuzawa, and M. Miyasaka Characterization of mac25/angiomodulin expression by high endothelial venule cells in lymphoid tissues and its identification as an inducible marker for activated endothelial cells Int. Immunol., November 1, 2002; 14(11): 1273 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Rubin and J. P. Bilezikian The Role of Parathyroid Hormone in the Pathogenesis of Glucocorticoid-Induced Osteoporosis: A Re-Examination of the Evidence J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4033 - 4041. [Full Text] [PDF] |
||||
![]() |
R. C. Pereira, D. Durant, and E. Canalis Transcriptional regulation of connective tissue growth factor by cortisol in osteoblasts Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E570 - E576. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hwa, Y. Oh, and R. G. Rosenfeld The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily Endocr. Rev., December 1, 1999; 20(6): 761 - 787. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |